Posts by ericg
Cooley team moves to Foley Hoag, attracted by DEI commitments
Boston-based law firm Foley Hoag LLP has scooped up a team from Cooley LLP to enhance its life sciences and IP practices. The team is led by Amy Baker Mandragouras, who joins the firm as a partner. Read More
Read MoreEditorial: Faster action, less red tape needed for cannabis equity
The state’s intention to create a more equitable cannabis industry here isn’t working out as intended. It’s time to remove the red tape that’s holding back equity applicants. Read More
Read MoreT woes, remote work spell opportunity for suburban chambers of commerce
Between the MBTA’s woes and remote and hybrid work policies, suburban chambers of commerce see a unique opportunity to draw new businesses and employees. Read More
Read MoreSamuel Adams, Accion Opportunity Fund reaches $100 million in small-business loans
A partnership between Boston Beer, maker of Samuel Adams, and a national nonprofit has given out $100 million in loans to thousands of small businesses across the country. Read More
Read MoreGreentown Labs names Kevin Knobloch, former DOE official, as CEO
Kevin Knobloch, 66, will be based in Somerville but plans to travel often to the climate-tech incubator’s Houston location. Read More
Read MoreCommentary: As ChatGPT ‘learns,’ focus on more human algorithms
Nations, institutions and businesses may soon turn to self-regulation over AI, and the algorithms governing academic journals publishing is a decent model, writes Chris Kenneally of the Copyright Clearance Center. Read More
Read MoreBiotech behind promising Covid vaccine pivots to veterinary medicine, spins off two divisions
Akston Biosciences Corporation is set to focus on drugs for animals, including insulin for dogs and cats, a cancer drug for dogs and a chronic pain drug for dogs. Read More
Read MoreThe Petri Dish: NeuroBo gets new CEO, FDA gives bluebird a positive sign
Some welcome news for bluebird bio: The FDA will not convene an advisory committee of outside experts to discuss lovo-cel, the company’s experimental gene therapy for sickle-cell disease, before it issues a final decision on the drug in December. Plus, other life sciences news you might have missed. Read More
Read MoreEra of the CFO: Financial leaders are in more demand than ever
The conversation has shifted from hiring CFOs and fractional, or part-time, financial leaders with a "grow fast and furious" mentality to a more long-term, strategic mind-set with an emphasis on operational skills. Some recruiters and founders said they’ve even seen an increase in requests for financial leaders, making it more difficult to fill this key…
Read MoreMassachusetts’ biggest hospitals are also the most expensive, CHIA report confirms
It’s significantly more expensive to receive health care at an academic medical center, such as Massachusetts General Hospital, than it is to receive care in a community hospital, new data confirms. Hospital executives say they recognize how much more expensive it is to care for patients in larger hospitals, and they are making efforts to…
Read More